Skip to Main content Skip to Navigation
Journal articles

Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper, Cerastes cerastes.

Abstract : Cerastatin, a potent platelet aggregation inhibitor, was purified by gel nitration on Sephadex G-75, followed by two ion exchange chromatographies on Mono-S columns. Cerastatin is a neutral glycoprotein (pI = 6.2) of 32 kDa, made up of at least three subunits. It is devoid of phospholipase A2, esterase, fibrinogenolytic and amidolytic activities. It inhibits aggregation of washed platelets, induced by either collagen, PAF acether or thrombin, with similar ic50 of 2.3 nM. Cerastatin also inhibits the thrombin-induced clot retraction of platelet-rich plasma. It does not inhibit the amidolytic or the procoagulant activities of thrombin. Cerastatin caused no lytic effect on platelet membranes since it did not cause release of lactate dehydrogenase. Pretreatment of platelets with cerastatin irreversibly inhibits the aggregation induced by thrombin. Also, cerastatin completely inhibits the fibrinogen-induced aggregation of a chymotrypsin-treated platelets. Cerastatin therefore inhibits platelet aggregation by interfering with the interaction of fibrinogen with fibrinogen receptors.
Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-01981492
Contributor : Abdelhakim Ben Hassine <>
Submitted on : Tuesday, January 15, 2019 - 10:02:30 AM
Last modification on : Wednesday, October 28, 2020 - 9:52:05 AM

Links full text

Identifiers

Collections

Citation

N. Marrakchi, Rym Barbouche, Cassian Bon, Mohamed Elayeb. Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper, Cerastes cerastes.. Toxicon, Elsevier, 1997, 35 (1), pp.125-135. ⟨10.1016/S0041-0101(96)00020-7⟩. ⟨pasteur-01981492⟩

Share

Metrics

Record views

109